Geode Capital Management, LLC C4 Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,369,676 shares of CCCC stock, worth $5.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,369,676

Previous 1,362,216 0.55%

Holding current value

$5.75 Million

Previous $6.29 Million 24.06%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.43 - $7.38 $33,047 - $55,054	7,460 Added 0.55%	1,369,676 $7.81 Million
Q2 2024 Aug 09, 2024	BUY	$4.05 - $8.1 $3.45 Million - $6.9 Million	851,901 Added 166.94%	1,362,216 $6.29 Million
Q1 2024 May 13, 2024	BUY	$5.3 - $11.0 $148,543 - $308,297	28,027 Added 5.81%	510,315 $4.17 Million
Q4 2023 Feb 13, 2024	BUY	$1.18 - $6.03 $31,203 - $159,457	26,444 Added 5.8%	482,288 $2.72 Million
Q3 2023 Nov 13, 2023	BUY	$1.81 - $3.89 $30,561 - $65,682	16,885 Added 3.85%	455,844 $847,000
Q2 2023 Aug 11, 2023	SELL	$2.75 - $3.77 $1.11 Million - $1.51 Million	-401,819 Reduced 47.79%	438,959 $1.21 Million
Q1 2023 May 15, 2023	BUY	$3.1 - $9.02 $134,806 - $392,243	43,486 Added 5.45%	840,778 $2.64 Million
Q4 2022 Feb 13, 2023	BUY	$5.42 - $10.24 $108,779 - $205,516	20,070 Added 2.58%	797,292 $4.7 Million
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $448,049 - $712,527	55,797 Added 7.73%	777,222 $6.82 Million
Q2 2022 Aug 12, 2022	BUY	$5.06 - $26.46 $271,246 - $1.42 Million	53,606 Added 8.03%	721,425 $5.44 Million
Q1 2022 May 13, 2022	SELL	$19.99 - $33.23 $366,956 - $610,003	-18,357 Reduced 2.68%	667,819 $16.2 Million
Q4 2021 Feb 11, 2022	BUY	$29.39 - $46.86 $583,479 - $930,311	19,853 Added 2.98%	686,176 $22.1 Million
Q3 2021 Nov 12, 2021	BUY	$35.91 - $50.5 $7.75 Million - $10.9 Million	215,781 Added 47.89%	666,323 $29.8 Million
Q2 2021 Aug 13, 2021	BUY	$30.39 - $42.18 $7.84 Million - $10.9 Million	257,950 Added 133.94%	450,542 $17 Million
Q1 2021 May 12, 2021	BUY	$31.96 - $46.5 $106,778 - $155,356	3,341 Added 1.77%	192,592 $7.12 Million
Q4 2020 Feb 12, 2021	BUY	$22.8 - $37.05 $4.31 Million - $7.01 Million	189,251 New	189,251 $6.27 Million

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $205M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC C4 Therapeutics, Inc. Transaction History